‘Extremely rare risk’ of heart inflammation after Pfizer and Moderna jabs – MHRA
The regulator stressed the benefits from either vaccine ‘greatly outweigh’ any potential risks.
The regulator stressed the benefits from either vaccine ‘greatly outweigh’ any potential risks.